Dr. John F. Valentine, MD

Dr. Valentine practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Valentine's NPI, 1144263419, was assigned on June 14, 2006. Dr. Valentine graduated from University of Texas Medical School at Houston in 1985. Dr. Valentine holds Utah license 8142989-1205.

Dr. Valentine's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Valentine's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Valentine is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valentine practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Valentine's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Valentine is licensed in Utah.

CMS data shows 111 Medicare services from Dr. Valentine across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $6,175 for them.

CMS counts 67 Medicare patients who saw Dr. Valentine in 2024. The largest group is 65 to 74, with 30 patients. 69% of them have high blood pressure, and 52% have arthritis. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valentine's median patient age at 65, with 42% women.

In 2024, Dr. Valentine wrote 371 Medicare Part D claims for 74 patients. 53% of them were for generic drugs. CMS names the drug for 201 of them, across 8 drugs with 11 or more claims each, at $1,742,440 in total drug cost. In 2023, CMS named 344 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Valentine for performance year 2024, reported as part of a group. Dr. Valentine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Valentine as offering telehealth. CMS counts 11 procedures of colonoscopy by Dr. Valentine, more than 41% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Valentine, published from 2010 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Crohn Disease, Inflammatory Bowel Diseases and Antibodies, Monoclonal, Humanized. Dr. Valentine has published most often in Inflamm Bowel Dis. Dr. Valentine's most frequent co-authors are Ann Debourcy Flynn, MD, Ellen J. Scherl, MD and Corey A. Siegel, MD.

Dmand AI links Dr. Valentine to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease.

CMS Open Payments shows 53 general payments to Dr. Valentine from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $6,371.

Dr. Valentine graduated from University of Texas Medical School at Houston in 1985.